Meibomian gland features in a Norwegian cohort of patients with primary Sjögren´s syndrome.

To assess the tear film and meibomian gland (MG) features in a Norwegian cohort of patients with primary Sjögren´s syndrome (pSS) and in age- and gender-matched control subjects.Thirty-four female patients with pSS (age 52.9±11.9 years) and 32 female control subjects (age 49.0±11.5 years) were recru...

Full description

Bibliographic Details
Main Authors: Xiangjun Chen, Øygunn Aass Utheim, Jiaxin Xiao, Muhammed Yasin Adil, Aleksandar Stojanovic, Behzod Tashbayev, Janicke Liaaen Jensen, Tor Paaske Utheim
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5590907?pdf=render
id doaj-46dc751a13c24a748eca4c6e17c0c39d
record_format Article
spelling doaj-46dc751a13c24a748eca4c6e17c0c39d2020-11-24T20:45:29ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-01129e018428410.1371/journal.pone.0184284Meibomian gland features in a Norwegian cohort of patients with primary Sjögren´s syndrome.Xiangjun ChenØygunn Aass UtheimJiaxin XiaoMuhammed Yasin AdilAleksandar StojanovicBehzod TashbayevJanicke Liaaen JensenTor Paaske UtheimTo assess the tear film and meibomian gland (MG) features in a Norwegian cohort of patients with primary Sjögren´s syndrome (pSS) and in age- and gender-matched control subjects.Thirty-four female patients with pSS (age 52.9±11.9 years) and 32 female control subjects (age 49.0±11.5 years) were recruited. After completion of Ocular Surface Disease Index (OSDI) questionnaire and McMonnies Dry Eye Questionaire, participants underwent measurements of tear osmolarity, tear break-up time (TBUT), ocular surface and corneal staining, Schirmer I test, corneal sensitivity, MG expressibility evaluations, and lid margin morphology examination using slitlamp microscopy. Non-contact infrared meibography images were assessed by computer-assisted analysis. The MG loss, calculated as (tarsal area-MG area)/tarsal area, was evaluated in both upper (UL) and lower lids (LL).Compared to the control group, pSS patients demonstrated higher MG loss in both UL (33.8±13.2% vs. 24.4±8.5%, p< 0.01) and LL (52.5±15.7% vs. 43.0±9.6%, p<0.05), as well as higher lid abnormality score (0.8±0.8 vs. 0.2±0.6, p< 0.01). Furthermore, pSS patients showed higher OSDI and McMonnies questionnaire scores, elevated osmolarity, shorter TBUT, shorter blink interval, less wetting in Schirmer I test, more ocular surface staining and more corneal staining. MG loss in UL correlated negatively with TBUT (r = -0.386, p = 0.029) in the pSS group, whereas MG loss in LL correlated negatively with TBUT (r = -0.380, p = 0.035) in the control group.Significantly elevated dry eye symptoms and signs were found in the pSS group compared with the control group, which might be attributed to both decreased aqueous tear production and increased tear evaporation.http://europepmc.org/articles/PMC5590907?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Xiangjun Chen
Øygunn Aass Utheim
Jiaxin Xiao
Muhammed Yasin Adil
Aleksandar Stojanovic
Behzod Tashbayev
Janicke Liaaen Jensen
Tor Paaske Utheim
spellingShingle Xiangjun Chen
Øygunn Aass Utheim
Jiaxin Xiao
Muhammed Yasin Adil
Aleksandar Stojanovic
Behzod Tashbayev
Janicke Liaaen Jensen
Tor Paaske Utheim
Meibomian gland features in a Norwegian cohort of patients with primary Sjögren´s syndrome.
PLoS ONE
author_facet Xiangjun Chen
Øygunn Aass Utheim
Jiaxin Xiao
Muhammed Yasin Adil
Aleksandar Stojanovic
Behzod Tashbayev
Janicke Liaaen Jensen
Tor Paaske Utheim
author_sort Xiangjun Chen
title Meibomian gland features in a Norwegian cohort of patients with primary Sjögren´s syndrome.
title_short Meibomian gland features in a Norwegian cohort of patients with primary Sjögren´s syndrome.
title_full Meibomian gland features in a Norwegian cohort of patients with primary Sjögren´s syndrome.
title_fullStr Meibomian gland features in a Norwegian cohort of patients with primary Sjögren´s syndrome.
title_full_unstemmed Meibomian gland features in a Norwegian cohort of patients with primary Sjögren´s syndrome.
title_sort meibomian gland features in a norwegian cohort of patients with primary sjögren´s syndrome.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2017-01-01
description To assess the tear film and meibomian gland (MG) features in a Norwegian cohort of patients with primary Sjögren´s syndrome (pSS) and in age- and gender-matched control subjects.Thirty-four female patients with pSS (age 52.9±11.9 years) and 32 female control subjects (age 49.0±11.5 years) were recruited. After completion of Ocular Surface Disease Index (OSDI) questionnaire and McMonnies Dry Eye Questionaire, participants underwent measurements of tear osmolarity, tear break-up time (TBUT), ocular surface and corneal staining, Schirmer I test, corneal sensitivity, MG expressibility evaluations, and lid margin morphology examination using slitlamp microscopy. Non-contact infrared meibography images were assessed by computer-assisted analysis. The MG loss, calculated as (tarsal area-MG area)/tarsal area, was evaluated in both upper (UL) and lower lids (LL).Compared to the control group, pSS patients demonstrated higher MG loss in both UL (33.8±13.2% vs. 24.4±8.5%, p< 0.01) and LL (52.5±15.7% vs. 43.0±9.6%, p<0.05), as well as higher lid abnormality score (0.8±0.8 vs. 0.2±0.6, p< 0.01). Furthermore, pSS patients showed higher OSDI and McMonnies questionnaire scores, elevated osmolarity, shorter TBUT, shorter blink interval, less wetting in Schirmer I test, more ocular surface staining and more corneal staining. MG loss in UL correlated negatively with TBUT (r = -0.386, p = 0.029) in the pSS group, whereas MG loss in LL correlated negatively with TBUT (r = -0.380, p = 0.035) in the control group.Significantly elevated dry eye symptoms and signs were found in the pSS group compared with the control group, which might be attributed to both decreased aqueous tear production and increased tear evaporation.
url http://europepmc.org/articles/PMC5590907?pdf=render
work_keys_str_mv AT xiangjunchen meibomianglandfeaturesinanorwegiancohortofpatientswithprimarysjogrenssyndrome
AT øygunnaassutheim meibomianglandfeaturesinanorwegiancohortofpatientswithprimarysjogrenssyndrome
AT jiaxinxiao meibomianglandfeaturesinanorwegiancohortofpatientswithprimarysjogrenssyndrome
AT muhammedyasinadil meibomianglandfeaturesinanorwegiancohortofpatientswithprimarysjogrenssyndrome
AT aleksandarstojanovic meibomianglandfeaturesinanorwegiancohortofpatientswithprimarysjogrenssyndrome
AT behzodtashbayev meibomianglandfeaturesinanorwegiancohortofpatientswithprimarysjogrenssyndrome
AT janickeliaaenjensen meibomianglandfeaturesinanorwegiancohortofpatientswithprimarysjogrenssyndrome
AT torpaaskeutheim meibomianglandfeaturesinanorwegiancohortofpatientswithprimarysjogrenssyndrome
_version_ 1716814608429219840